Kiniksa Pharmaceuticals sees highest patent filings and grants during April in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Kiniksa Pharmaceuticals here.
Sun.Jul 21, 2024
130 
Health ministry issues draft rules for compounding of certain offences under drug regulations
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 21, 2024
The Union health ministry has issued a draft notification framing the rules related to compounding of offences for minor offences under the drug regulations.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kiniksa Pharmaceuticals sees highest patent filings and grants during April in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Kiniksa Pharmaceuticals here.
Which pharmaceutical drugs have the most drug patents in Austria?
Drug Patent Watch
JULY 21, 2024
This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
Dechra Pharmaceuticals sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Dechra Pharmaceuticals here.
New tentative approval for Alembic drug dabigatran etexilate mesylate
Drug Patent Watch
JULY 21, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Stand by Your Case? Without Standing, Supreme Court Precedent Means You’ll Have More Bad Times than Good
FDA Law Blog
JULY 21, 2024
By John W.M. Claud — Sometimes it’s difficult to be a plaintiff, putting all your work into just one case. That’s especially true if recent Supreme Court rulings have rendered your matter a quixotic pursuit, doomed to fail for lack of direct causation. That’s what happened last week in District Court in Maryland. Following the precedent on standing that the Supreme Court handed down in June in FDA v.
Dechra Pharmaceuticals sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Dechra Pharmaceuticals here.
Understanding the Patent Trial and Appeal Board (PTAB) – A Comprehensive Overview
Drug Patent Watch
JULY 21, 2024
The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office (USPTO), established in 2012 by the Leahy-Smith America Invents Act (AIA).
Oramed Pharmaceuticals sees highest patent filings and grants during April in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Oramed Pharmaceuticals here.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
IT outage raises resilience, security concerns in healthcare
pharmaphorum
JULY 21, 2024
As healthcare systems try to recover from major outage event, attention turns to potential fraud and resiliency concerns
Y-mAbs Therapeutics sees highest patent filings and grants during June in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Y-mAbs Therapeutics here.
Y-mAbs Therapeutics sees highest patent filings and grants during June in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Y-mAbs Therapeutics here.
iTeos Therapeutics sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for iTeos Therapeutics here.
iTeos Therapeutics sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for iTeos Therapeutics here.
Medicover sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Medicover here.
Medicover sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Medicover here.
Oscotec sees highest patent filings and grants during June in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Oscotec here.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Certara sees highest patent filings and grants during June in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Certara here.
Oscotec sees highest patent filings and grants during June in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Oscotec here.
Certara sees highest patent filings and grants during June in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Certara here.
Medios sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Medios here.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Medios sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Medios here.
Orion sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Orion here.
Orion sees highest patent filings and grants during May in Q2 2024
Pharmaceutical Technology
JULY 21, 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Orion here.
Let's personalize your content